XORTX Therapeutics Inc. (Form 6-K Summary)

This filing for October 2025 serves primarily to incorporate material exhibits into the existing Form F-3 Registration Statement (File No. 333-269429).

Key incorporated exhibits for investors include:

• Exhibit 99.1: A Press Release dated October 29, 2025 (Contents are not summarized here, but this likely holds key operational or financial news).
• Exhibits 99.2 & 99.3: Legal opinions confirming the legality of securities being registered.

The report was certified by CEO Allen Davidoff. Investors should review Exhibit 99.1 for cu